Holbrook A - Search Results

1

What Influences the Cost Effectiveness of Dabigatran versus Warfarin for Stroke Prevention in Atrial Fibrillation: A Systematic Review.

Jegathisawaran J, Holbrook A, Bowen JM, Burke N, Campbell K, Tarride JE. Jegathisawaran J, et al. Among authors: holbrook a. J Popul Ther Clin Pharmacol. 2017 May 2;24(2):e1-e20. doi: 10.22374/1710-6222.24.2.1. J Popul Ther Clin Pharmacol. 2017. PMID: 28594478 Review.

2

Placebos: our most effective therapy?

Holbrook A, Goldsmith C. Holbrook A, et al. Can J Clin Pharmacol. 2004 Spring;11(1):e39-40. Epub 2004 Apr 1. Can J Clin Pharmacol. 2004. PMID: 15226525

3

Systematic overview of warfarin and its drug and food interactions.

Holbrook AM, Pereira JA, Labiris R, McDonald H, Douketis JD, Crowther M, Wells PS. Holbrook AM, et al. Arch Intern Med. 2005 May 23;165(10):1095-106. doi: 10.1001/archinte.165.10.1095. Arch Intern Med. 2005. PMID: 15911722 Review.

4

A systematic review of medication safety outcomes related to drug interaction software.

Wong K, Yu SK, Holbrook A. Wong K, et al. Among authors: holbrook a. J Popul Ther Clin Pharmacol. 2010 Summer;17(2):e243-55. Epub 2010 Jul 6. J Popul Ther Clin Pharmacol. 2010. PMID: 20664117 Review.

5

Cost-effectiveness of a shared computerized decision support system for diabetes linked to electronic medical records.

O'Reilly D, Holbrook A, Blackhouse G, Troyan S, Goeree R. O'Reilly D, et al. Among authors: holbrook a. J Am Med Inform Assoc. 2012 May-Jun;19(3):341-5. doi: 10.1136/amiajnl-2011-000371. Epub 2011 Nov 3. J Am Med Inform Assoc. 2012. PMID: 22052900 Free PMC article.

6

Anticoagulation control with daily low-dose vitamin k to reduce clinically adverse outcomes and international normalized ratio variability: a systematic review and meta-analysis.

Lam J, Schulman S, Witt DM, Vandvik PO, Qayyum F, Holbrook AM. Lam J, et al. Pharmacotherapy. 2013 Nov;33(11):1184-90. doi: 10.1002/phar.1302. Epub 2013 Jun 6. Pharmacotherapy. 2013. PMID: 23744743 Review.

7

Validation of a patient decision aid for choosing between dabigatran and warfarin for atrial fibrillation.

Hong C, Kim S, Curnew G, Schulman S, Pullenayegum E, Holbrook A. Hong C, et al. Among authors: holbrook a. J Popul Ther Clin Pharmacol. 2013;20(3):e229-37. Epub 2013 Sep 6. J Popul Ther Clin Pharmacol. 2013. PMID: 24163147 Clinical Trial.

8

Prediction of individual combined benefit and harm for patients with atrial fibrillation considering warfarin therapy: a study protocol.

Li G, Holbrook A, Delate T, Witt DM, Levine MA, Thabane L. Li G, et al. Among authors: holbrook a. BMJ Open. 2015 Nov 5;5(11):e009518. doi: 10.1136/bmjopen-2015-009518. BMJ Open. 2015. PMID: 26546146 Free PMC article.

9

Comparison of treatment effect estimates of non-vitamin K antagonist oral anticoagulants versus warfarin between observational studies using propensity score methods and randomized controlled trials.

Li G, Holbrook A, Jin Y, Zhang Y, Levine MA, Mbuagbaw L, Witt DM, Crowther M, Connolly S, Chai-Adisaksopha C, Wan Z, Cheng J, Thabane L. Li G, et al. Among authors: holbrook a. Eur J Epidemiol. 2016 Jun;31(6):541-61. doi: 10.1007/s10654-016-0178-y. Epub 2016 Jul 1. Eur J Epidemiol. 2016. PMID: 27370013

10

Development and validation of a decision aid for choosing among antithrombotic agents for atrial fibrillation.

Fatima S, Holbrook A, Schulman S, Park S, Troyan S, Curnew G. Fatima S, et al. Among authors: holbrook a. Thromb Res. 2016 Sep;145:143-8. doi: 10.1016/j.thromres.2016.06.015. Epub 2016 Jun 16. Thromb Res. 2016. PMID: 27388221

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

434 results

Search Page